An Open Trial of a Smartphone-assisted, Adjunctive Intervention to Improve Treatment Adherence in Bipolar Disorder

被引:17
作者
Wenze, Susan J. [1 ,2 ]
Armey, Michael F. [2 ,3 ]
Weinstock, Lauren M. [2 ,3 ]
Gaudiano, Brandon A. [2 ,3 ]
Miller, Ivan W. [2 ,3 ]
机构
[1] Lafayette Coll, Dept Psychol, Easton, PA 18042 USA
[2] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA
关键词
adherence; bipolar disorder; ecological momentary intervention; mobile health; smartphone; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; LITHIUM MAINTENANCE; MOBILE INTERVENTION; ADDICTIVE-DISORDERS; MOOD STABILIZERS; SUBSTANCE USE; PRIMARY-CARE; HEALTH; HOSPITALIZATION;
D O I
10.1097/PRA.0000000000000196
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the feasibility and acceptability of a novel, 12-week, adjunctive, smartphone-assisted intervention to improve treatment adherence in bipolar disorder. Eight participants completed 4 in-person individual therapy sessions over the course of a month, followed by 60 days of twice-daily ecological momentary intervention (EMI) sessions, with a fifth in-person session after 30 days and a sixth in-person session after 60 days. Perceived credibility of the intervention and expectancy for change were adequate at baseline, and satisfaction on completion of the intervention was very high. Participants demonstrated good adherence to the intervention overall, including excellent adherence to the in-person component and fair adherence to the smartphone-facilitated component. Qualitative feedback revealed very high satisfaction with the in-person sessions and suggested a broad range of ways in which the EMI sessions were helpful. Participants also provided suggestions for improving the intervention, which primarily related to the structure and administration of the EMI (smartphone-administered) sessions. Although this study was not designed to evaluate treatment efficacy, most key outcome variables changed in the expected directions from pretreatment to posttreatment, and several variables changed significantly over the course of the in-person sessions or during the EMI phase. These findings add to the small but growing body of literature suggesting that EMIs are feasible and acceptable for use in populations with bipolar disorder.
引用
收藏
页码:492 / 504
页数:13
相关论文
共 50 条
  • [41] Treatment adherence with antipsychotic medications in bipolar disorder
    Sajatovic, M
    Valenstein, M
    Blow, FC
    Ganoczy, D
    Ignacio, RV
    [J]. BIPOLAR DISORDERS, 2005, 7 : 94 - 94
  • [42] Treatment adherence with antipsychotic medications in bipolar disorder
    Sajatovic, Martha
    Valenstein, Marcia
    Blow, Frederic C.
    Ganoczy, Dara
    Ignacio, Rosalinda V.
    [J]. BIPOLAR DISORDERS, 2006, 8 (03) : 232 - 241
  • [43] Strategies for increasing treatment adherence in bipolar disorder
    Soykan, Atilla
    [J]. JOURNAL OF MOOD DISORDERS, 2013, 3 : S9 - S10
  • [44] Improving treatment adherence in bipolar disorder - A review of current psychosocial treatment efficacy and recommendations for future treatment development
    Gaudiano, Brandon A.
    Weinstock, Lauren A.
    Miller, Ivan W.
    [J]. BEHAVIOR MODIFICATION, 2008, 32 (03) : 267 - 301
  • [45] Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder
    Gianfrancesco, Frank D.
    Sajatovic, Martha
    Tafesse, Eskinder
    Wang, Ruey-Hua
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2009, 21 (01) : 3 - 16
  • [46] An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder
    Wilens, TE
    Prince, JB
    Spencer, T
    Van Patten, SL
    Doyle, R
    Girard, K
    Hammerness, P
    Goldman, S
    Brown, S
    Biederman, J
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 54 (01) : 9 - 16
  • [47] Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial
    Mitchell, John T.
    LeGrand, Sara
    Hightow-Weidman, Lisa B.
    McKellar, Mehri S.
    Kashuba, Angela D. M.
    Cottrell, Mackenzie
    McLaurin, Tony
    Satapathy, Goutam
    McClernon, F. Joseph
    [J]. JMIR MHEALTH AND UHEALTH, 2018, 6 (09):
  • [48] LiveWell, a smartphone-based self-management intervention for bipolar disorder: Intervention participation and usability analysis
    Jonathan, Geneva K.
    Abitante, George
    McBride, Alyssa
    Bernstein-Sandler, Mary
    Babington, Pamela
    Dopke, Cynthia A.
    Rossom, Rebecca C.
    Mohr, David C.
    Goulding, Evan H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 350 : 926 - 936
  • [49] Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy
    Pande, AC
    Crockatt, JG
    Janney, CA
    Werth, JL
    Tsaroucha, G
    [J]. BIPOLAR DISORDERS, 2000, 2 (03) : 249 - 255
  • [50] Assessing the treatment adherence and clinical correlates of low adherence among bipolar disorder outpatients: a cross-sectional study
    Karadag, Hasan
    Kokurcan, Ahmet
    Guriz, Seher Olga
    Atmar, Mehlika
    Orsel, Sibel
    [J]. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (04) : 558 - 564